Figure 1
![Figure 1. KL dose-response in β thalassemic patients. Cell growth (top panels) and HbF content (bottom panels) in minibulk HPC unilineage erythroid cultures derived from a representative β-TI (left panels) and β-TM patient (right panels), supplemented or not with graded amounts of KL (1, 10, or 100 ng/mL). The total cell number is shown in top panels. The percentage of HbF content (evaluated as the γ/[β + γ] and γ/α ratio in β-TI and β-TM, respectively) is reported in bottom panels.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/111/1/10.1182_blood-2007-06-097550/3/zh80040812900001.jpeg?Expires=1735610594&Signature=B2bxbBnMERE0Whfy1OR7KTd1LNS-be~kHVOnHX35y34jI-2eZlaci61bzSabASL9B6cSmtl0nFGycl5~EdV~iZ1m2As3zE70N1qf481PhYqtWV1aRiwYnD9ZoY70gUvgGmNK8o5RYcoW7buo53kWP8X5YNKNxouv~jk~q1uxTpEYML7dy2efLkZQFPVkkbommKH2fmlSrAhjUtQCdCkjmcF~uPCRq~U3l9Q9pwIo5-UrKggtne4UlRmeemwdhp~-0lJ4pXWIT24yX-yCIBBYN2C8klGdTG4kApGFTQ6Y1ajDWyEzGzC~rPaLY30H6isT1fokNW2rGJVjJWpYhNgzDA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
KL dose-response in β thalassemic patients. Cell growth (top panels) and HbF content (bottom panels) in minibulk HPC unilineage erythroid cultures derived from a representative β-TI (left panels) and β-TM patient (right panels), supplemented or not with graded amounts of KL (1, 10, or 100 ng/mL). The total cell number is shown in top panels. The percentage of HbF content (evaluated as the γ/[β + γ] and γ/α ratio in β-TI and β-TM, respectively) is reported in bottom panels.
